Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) NSE

161.70

+2.78(+1.75%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap3B
Enterprise Value3.33B
P/E Ratio6.88
PEG Ratio1.65
Price/Sales Ratio0.74
Price/Book Ratio0.47
Enterprise/Revenue1.11
Enterprise/EBITDA7.33

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.12

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue3.65B
Revenue/Share211.73
Gross Profit2.29B
EBITDA497.98M
Net Income386M
Diluted EPS20.31

Balance Sheet

Total Cash1.59B
Total Cash/Share80.78
Total Debt1.55B
Total Debt/Equity0.23
Current Ratio2.23
Book Value Per Share345.69

Price History

52-Week Change-13.41
52-Week High238.69
52-Week Low137.55
Moving Average 50 Days161.25
Moving Average 200 Days173.4

Statistics

Average Volume19,546
Shares Outstanding19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2
Trailing Annual Dividend Yield1.24
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A